Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Cholangiocarcinoma
Interventions
DIAGNOSTIC_TEST

Proteomic profile

"Proteomic analysis of bile samples will be performed every 5 bile samples. Bile samples will be taken during endoscopy with retrograde papillary catheterization or radiological procedures in selected patients. In clinical practice, bile samples are taken for bacteriological purposes. An average of 10 mL is taken.~Five mL are required for bacteriological analysis. The remaining millilitres, which are usually discarded, will be kept for storage and to form the bile bank at the Biological Resources Centre before to be analyzed in proteomics."

Trial Locations (1)

Unknown

CHU Bordeaux, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT06416397 - Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy | Biotech Hunter | Biotech Hunter